← Back to Clinical Trials
Recruiting NCT06972121

NCT06972121 Digital Mindset Intervention for Half Marathon Performance

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06972121
Status Recruiting
Phase
Sponsor University of Auckland, New Zealand
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 207 participants
Start Date 2025-05-15
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindset InterventionMarathon Performance Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 207 participants in total. It began in 2025-05-15 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized controlled trial is to test whether a brief digital mindset training program can improve performance among recreational runners training for a half marathon in New Zealand in 2025. The study will recruit healthy adult participants who are registered for an upcoming half-marathon event. The study aims to answer two main questions: 1. Does the mindset training program - designed to reframe common physical symptoms like fatigue or muscle soreness as signs of progress - help more runners complete the race and improve their official times, compared to standard training advice? 2. Does it support better training (e.g., longer peak training weeks) and faster physical recovery after the race? Researchers will compare participants who receive the mindset training program to those who receive widely followed half-marathon training content and a group who receive no study content, to see whether the mindset training leads to better half-marathon performance and training outcomes. Participants will: * Complete a brief online survey at the start of the study * Receive and engage with four pieces of digital content across nine weeks before the half-marathon race (if assigned to a training group) * Complete a follow-up survey after the half-marathon

Eligibility Criteria

Inclusion Criteria: * Be aged 18 years or older * Be registered to run (not walk) in a 2025 half marathon in New Zealand * Be running their 1st, 2nd, or 3rd half marathon * Be able to complete the half-marathon without physical assistance or aids * Be able to read and understand English * Have regular access to email or an internet-connected device Exclusion Criteria: * Have completed more than 2 half marathons in the past * Are currently injured or unable to complete the race unassisted * Are unable to complete online questionnaires independently * Do not have access to a device capable of receiving digital content via app or email

Contact & Investigator

Central Contact

Michelle Taylorson, Health Psychology Masters Stud

✉ mtay322@aucklanduni.ac.nz

📞 +64 21 230 8053

Principal Investigator

Keith Petrie, Professor

PRINCIPAL INVESTIGATOR

University of Auckland, New Zealand

Frequently Asked Questions

Who can join the NCT06972121 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06972121 currently recruiting?

Yes, NCT06972121 is actively recruiting participants. Contact the research team at mtay322@aucklanduni.ac.nz for enrollment information.

Where is the NCT06972121 trial being conducted?

This trial is being conducted at Auckland, New Zealand.

Who is sponsoring the NCT06972121 clinical trial?

NCT06972121 is sponsored by University of Auckland, New Zealand. The principal investigator is Keith Petrie, Professor at University of Auckland, New Zealand. The trial plans to enroll 207 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology